Lakefront Biotherapeutics NV

OTCPK:GLPG.F Stock Report

Market Cap: US$1.8b

Lakefront Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GLPG.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders10,2740.0156%
VC/PE Firms4,635,6727.03%
Public Companies16,707,47725.4%
Institutions21,748,45733%
General Public22,795,19134.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.4%
Gilead Sciences, Inc.
16,707,477US$464.2m0%no data
7.67%
Tang Capital Management, LLC
5,052,564US$140.4m-2.61%6.36%
7.03%
Van Herk Investments B.V.
4,635,672US$128.8m0%23.57%
3.74%
Madison Avenue Partners, LP
2,465,179US$68.5m11.4%2.11%
3.07%
The Vanguard Group, Inc.
2,023,070US$56.2m-0.16%no data
2.53%
EcoR1 Capital, LLC
1,667,119US$46.3m0%1.8%
2.35%
Prosight Management, LP
1,550,000US$43.1m44.3%7.18%
2.16%
Columbia Management Investment Advisers, LLC
1,424,674US$39.6m-1.83%0.01%
1.67%
BlackRock, Inc.
1,099,564US$30.5m0.55%no data
1.59%
Norges Bank Investment Management
1,046,002US$29.1m0%no data
1.24%
Dimensional Fund Advisors LP
820,141US$22.8m2.46%no data
0.73%
Greenlight Capital, Inc.
482,746US$13.4m0%0.37%
0.65%
Segall Bryant & Hamill, LLC
428,086US$11.9m-4.47%0.17%
0.5%
Point72 Asset Management, L.P.
332,125US$9.2m-31.7%0.01%
0.48%
Renaissance Technologies LLC
315,400US$8.8m1.55%0.01%
0.43%
UBS Asset Management AG
282,154US$7.8m-38.2%no data
0.39%
Merrill Lynch, Pierce, Fenner & Smith Incorporated
253,781US$7.1m1,710%no data
0.35%
Monocle
233,740US$6.5m0%30.67%
0.33%
D. E. Shaw & Co., L.P.
215,718US$6.0m-21.6%no data
0.29%
Bank of America Corporation
188,033US$5.2m1,010%no data
0.21%
Charles Schwab Investment Management, Inc.
139,514US$3.9m0.29%no data
0.2%
Dafna Capital Management, LLC
130,175US$3.6m0%0.78%
0.18%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
121,891US$3.4m-68.2%no data
0.16%
State Street Global Advisors, Inc.
108,553US$3.0m-0.17%no data
0.16%
Millennium Management LLC
107,912US$3.0m-68.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/22 21:12
End of Day Share Price 2026/05/04 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lakefront Biotherapeutics NV is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily FieldBarclays
Xue ChenBarclays
Patrick TrucchioBerenberg